Skip to content
Clinical Trials – home

Bicetre Hospital

Verified siteinfo

France 78 Rue Du General Leclerc, 94275 Le Kremlin-Bicetre, France

  • 42 trials recruiting
  • Sjogren's syndrome · Juvenile idiopathic arthritis · Pulmonary arterial hypertension
  • Adults and children

About Specializations

Bicetre Hospital in Le Kremlin-Bicetre, France specialises in clinical trials of conditions such as Sjogren's syndrome, Juvenile idiopathic arthritis, Pulmonary arterial hypertension, Juvenile psoriatic arthritis, and other specialisations. This site conducts important research.

Main research areas of the site

Rheumatology and Pediatric Inflammatory Disease Research

At Bicetre Hospital, the Service de Rhumatologie is involved in studies focused on immune system diseases and skin and connective tissue diseases, with a strong emphasis on inflammatory conditions in children and adolescents. The research is designed to better understand and improve care for juvenile idiopathic arthritis and related forms of arthritis.

  • Studies in juvenile idiopathic arthritis and related pediatric arthritis conditions
  • Research on enthesitis-related arthritis and juvenile psoriatic arthritis
  • Evaluation of new treatments aimed at improving symptom control and disease outcomes

These trials are helping assess how well emerging therapies work in young patients living with chronic inflammatory joint disease.

Autoimmune and Systemic Disease Studies

Clinical research at this site also covers immune system diseases and broader immune system phenomena, including work on complex autoimmune conditions such as Sjögren’s syndrome. The goal is to improve treatment options for people with moderate to severe systemic disease activity.

  • Research in Sjögren’s syndrome with systemic involvement
  • Studies examining control of broader autoimmune symptoms and organ-related effects
  • Testing whether new therapies can reduce disease activity and improve daily functioning

This area of research reflects a focus on treatments that may better address the full impact of systemic autoimmune disease.

Neurology-Related Amyloidosis Research

The trial portfolio at Bicetre Hospital includes research in nervous system diseases and rare inherited disorders, especially hereditary transthyretin-mediated amyloidosis with polyneuropathy. These studies aim to determine whether new therapies can help preserve nerve function and reduce neurologic impairment.

  • Investigation of hereditary transthyretin-mediated amyloidosis with polyneuropathy
  • Assessment of treatments intended to slow nerve damage and improve neurologic outcomes
  • Rare disease research with a focus on symptom relief and disease control

This work supports efforts to improve care for patients affected by a progressive inherited condition that can strongly affect the nerves.

Translational Pediatric Rheumatology and Treatment Evaluation

Across its clinical studies, the site contributes to research that spans congenital, hereditary, and neonatal diseases and abnormalities as well as inflammatory conditions linked to the immune system. The trials are centered on understanding how therapies behave in younger patients and on evaluating their effectiveness in real clinical settings.

  • Drug behavior and treatment response research in children and adolescents
  • Clinical evaluation of therapies for inflammatory joint disease
  • Studies aimed at improving long-term disease management and patient outcomes

This research profile highlights a mix of pediatric rheumatology, autoimmune disease, and rare disease studies, showing a broad interest in improving care for both common and uncommon conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
78 Rue Du General Leclerc94275 Le Kremlin-BicetreFrance
Recruiting now
42 trials
Conditions studied
81
Partner status
Verified site

More sites in Le Kremlin-BicetreFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

97 clinical trials

A Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Empasiprubart
  • Sponsor:Argenx

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.

Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

A Study of ANX005 for Patients Recently Diagnosed with Guillain-Barré Syndrome to Evaluate How the Drug Works in the Body and Its Safety

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Humanised IgG4 monoclonal antibody against C1Q
  • Sponsor:Annexon Inc.

Evaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Emicizumab
  • Sponsor:F. Hoffmann-La Roche AG

A Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:RO7589655
  • Sponsor:F. Hoffmann-La Roche AG

Crohn's disease

Recruiting

One-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Guselkumab
  • Sponsor:Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif

A study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Polyneuropathy

Recruiting

A study to evaluate the safety and effectiveness of nucresiran and vutrisiran in patients with hereditary transthyretin amyloidosis with polyneuropathy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Vutrisiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Canavan disease

Recruiting

A study to evaluate the effectiveness of ciracigene golparvovec in children with Canavan disease

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Sponsor:Myrtelle Inc.

Still's disease

Recruiting

A Study of MAS825 in Children and Adults with Still's Disease to Test How Well It Works and How Safe It Is

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Human Igg1 Monoclonal Antibody Against Human Il-1 Beta And Human Il-18
  • Sponsor:Novartis Pharma AG

Study of Vosoritide Safety and Effectiveness in Infants and Young Children (0 to 36 months) with Hypochondroplasia

Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Vosoritide
  • Sponsor:Biomarin Pharmaceutical Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.